Yang Yang

Inhibition of HDACs-EphA2 Signaling Axis with WW437 Demonstrates Promising Preclinical Antitumor Activity in Breast Cancer

Mingyao Liu, Yuan He, Z. Yi, 2018, EBioMedicine.

Development of hydroxamate-based histone deacetylase inhibitors of bis-substituted aromatic amides with antitumor activities.

Yihua Chen, Hua Zhang, N. Zhao, 2019, MedChemComm.

Design and optimization of novel hydroxamate-based histone deacetylase inhibitors of Bis-substituted aromatic amides bearing potent activities against tumor growth and metastasis.

Tao Zhang, Mingyao Liu, Xiufeng Pang, 2014, Journal of medicinal chemistry.

Synthesis and biological evaluation of thiophene-based hydroxamate derivatives as HDACis with antitumor activities.

Yihua Chen, Hua Zhang, N. Zhao, 2020, Future medicinal chemistry.

Design and optimization of novel hydroxamate-based histone deacetylase inhibitors of Bis-substituted aromatic amides bearing potent activities against tumor growth and metastasis.

Tao Zhang, Mingyao Liu, Xiufeng Pang, 2014, Journal of medicinal chemistry.